248 related articles for article (PubMed ID: 21358326)
1. HIV-associated nephropathy: pathogenesis.
Medapalli RK; He JC; Klotman PE
Curr Opin Nephrol Hypertens; 2011 May; 20(3):306-11. PubMed ID: 21358326
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
3. APOL1 localization in normal kidney and nondiabetic kidney disease.
Madhavan SM; O'Toole JF; Konieczkowski M; Ganesan S; Bruggeman LA; Sedor JR
J Am Soc Nephrol; 2011 Nov; 22(11):2119-28. PubMed ID: 21997392
[TBL] [Abstract][Full Text] [Related]
4. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
Papeta N; Kiryluk K; Patel A; Sterken R; Kacak N; Snyder HJ; Imus PH; Mhatre AN; Lawani AK; Julian BA; Wyatt RJ; Novak J; Wyatt CM; Ross MJ; Winston JA; Klotman ME; Cohen DJ; Appel GB; D'Agati VD; Klotman PE; Gharavi AG
J Am Soc Nephrol; 2011 Nov; 22(11):1991-6. PubMed ID: 21997397
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of HIV-associated nephropathy.
Kaufman L; Collins SE; Klotman PE
Adv Chronic Kidney Dis; 2010 Jan; 17(1):36-43. PubMed ID: 20005487
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated nephropathy.
Wyatt CM; Rosenstiel PE; Klotman PE
Contrib Nephrol; 2008; 159():151-161. PubMed ID: 18391591
[TBL] [Abstract][Full Text] [Related]
7. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
[TBL] [Abstract][Full Text] [Related]
8. APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle.
Hays T; Wyatt CM
Kidney Int; 2012 Aug; 82(3):259-60. PubMed ID: 22791322
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of HIV-associated nephropathy.
Leventhal JS; Ross MJ
Semin Nephrol; 2008 Nov; 28(6):523-34. PubMed ID: 19013323
[TBL] [Abstract][Full Text] [Related]
10. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy.
Zhong J; Zuo Y; Ma J; Fogo AB; Jolicoeur P; Ichikawa I; Matsusaka T
Kidney Int; 2005 Sep; 68(3):1048-60. PubMed ID: 16105035
[TBL] [Abstract][Full Text] [Related]
11. [HIV-1 and renal cells: pathogenesis of HIV-associated nephropathy].
Conaldi PG; Camussi G
G Ital Nefrol; 2005; 22(6):569-80. PubMed ID: 16342049
[TBL] [Abstract][Full Text] [Related]
12. APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease.
Fine DM; Wasser WG; Estrella MM; Atta MG; Kuperman M; Shemer R; Rajasekaran A; Tzur S; Racusen LC; Skorecki K
J Am Soc Nephrol; 2012 Feb; 23(2):343-50. PubMed ID: 22135313
[TBL] [Abstract][Full Text] [Related]
13. Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene.
Núñez M; Saran AM; Freedman BI
Adv Chronic Kidney Dis; 2010 Jan; 17(1):44-51. PubMed ID: 20005488
[TBL] [Abstract][Full Text] [Related]
14. Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.
Mikulak J; Oriolo F; Portale F; Tentorio P; Lan X; Saleem MA; Skorecki K; Singhal PC; Mavilio D
Retrovirology; 2016 Sep; 13(1):63. PubMed ID: 27599995
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression.
Papeta N; Chan KT; Prakash S; Martino J; Kiryluk K; Ballard D; Bruggeman LA; Frankel R; Zheng Z; Klotman PE; Zhao H; D'Agati VD; Lifton RP; Gharavi AG
J Clin Invest; 2009 May; 119(5):1178-88. PubMed ID: 19381020
[TBL] [Abstract][Full Text] [Related]
16. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
[TBL] [Abstract][Full Text] [Related]
17. APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.
Kopp JB; Heymann J; Winkler CA
Semin Nephrol; 2017 Nov; 37(6):514-519. PubMed ID: 29110758
[TBL] [Abstract][Full Text] [Related]
18. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.
Atta MG; Estrella MM; Kuperman M; Foy MC; Fine DM; Racusen LC; Lucas GM; Nelson GW; Warner AC; Winkler CA; Kopp JB
Kidney Int; 2012 Aug; 82(3):338-43. PubMed ID: 22495294
[TBL] [Abstract][Full Text] [Related]
19. Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
Behar DM; Kedem E; Rosset S; Haileselassie Y; Tzur S; Kra-Oz Z; Wasser WG; Shenhar Y; Shahar E; Hassoun G; Maor C; Wolday D; Pollack S; Skorecki K
Am J Nephrol; 2011; 34(5):452-9. PubMed ID: 21968148
[TBL] [Abstract][Full Text] [Related]
20. The molecular pathogenesis of HIV-1 associated nephropathy: recent advances.
Papeta N; Sterken R; Kiryluk K; Kalyesubula R; Gharavi AG
J Mol Med (Berl); 2011 May; 89(5):429-36. PubMed ID: 21221512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
